Works matching AU Shimokawa, Mototsugu

Results: 206
    1

    Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).

    Published in:
    2018
    By:
    • Akito Hata;
    • Nobuyuki Katakami;
    • Mototsugu Shimokawa;
    • Tetsuya Mitsudomi;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawa;
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Shimokawa, Mototsugu;
    • Mitsudomi, Tetsuya;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    2
    3

    A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non-Small-Cell Lung Cancer Patients.

    Published in:
    2017
    By:
    • Kazuki Takada;
    • Gouji Toyokawa;
    • Tatsuro Okamoto;
    • Mototsugu Shimokawa;
    • Yuka Kozuma;
    • Taichi Matsubara;
    • Naoki Haratake;
    • Takaki Akamine;
    • Shinkichi Takamori;
    • Masakazu Katsura;
    • Fumihiro Shoji;
    • Yoshinao Oda;
    • Yoshihiko Maehara;
    • Takada, Kazuki;
    • Toyokawa, Gouji;
    • Okamoto, Tatsuro;
    • Shimokawa, Mototsugu;
    • Kozuma, Yuka;
    • Matsubara, Taichi;
    • Haratake, Naoki
    Publication type:
    journal article
    4

    Relationship between hyperemesis gravidarum and small-for-gestational-age in the Japanese population: the Japan Environment and Children's Study (JECS).

    Published in:
    2016
    By:
    • Seiichi Morokuma;
    • Mototsugu Shimokawa;
    • Kiyoko Kato;
    • Masafumi Sanefuji;
    • Eiji Shibata;
    • Mayumi Tsuji;
    • Ayako Senju;
    • Toshihiro Kawamoto;
    • Koichi Kusuhara;
    • Morokuma, Seiichi;
    • Shimokawa, Mototsugu;
    • Kato, Kiyoko;
    • Sanefuji, Masafumi;
    • Shibata, Eiji;
    • Tsuji, Mayumi;
    • Senju, Ayako;
    • Kawamoto, Toshihiro;
    • Kusuhara, Koichi;
    • Japan Environment & Children’s Study Group
    Publication type:
    journal article
    5

    CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resection.

    Published in:
    International Journal of Clinical Oncology, 2025, v. 30, n. 7, p. 1319, doi. 10.1007/s10147-025-02771-9
    By:
    • Matsudo, Kyoto;
    • Takada, Kazuki;
    • Hashinokuchi, Asato;
    • Nagano, Taichi;
    • Kinoshita, Fumihiko;
    • Akamine, Takaki;
    • Kohno, Mikihiro;
    • Takenaka, Tomoyoshi;
    • Shimokawa, Mototsugu;
    • Oda, Yoshinao;
    • Yoshizumi, Tomoharu
    Publication type:
    Article
    6
    7
    8

    Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non–small-cell Lung Cancer: SQUAT trial (WJOG 12119L).

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 6, p. 596, doi. 10.1016/j.cllc.2021.04.006
    By:
    • Hamada, Akira;
    • Soh, Junichi;
    • Hata, Akito;
    • Nakamatsu, Kiyoshi;
    • Shimokawa, Mototsugu;
    • Yatabe, Yasushi;
    • Oizumi, Hiroyuki;
    • Tsuboi, Masahiro;
    • Horinouchi, Hidehito;
    • Yoshino, Ichiro;
    • Tanahashi, Masayuki;
    • Toyooka, Shinichi;
    • Okada, Morihito;
    • Yokomise, Hiroyasu;
    • Yamashita, Motohiro;
    • Nishimura, Yasumasa;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Mitsudomi, Tetsuya
    Publication type:
    Article
    9

    A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
    By:
    • Takeda, Masayuki;
    • Shimokawa, Mototsugu;
    • Nakamura, Atsushi;
    • Nosaki, Kaname;
    • Watanabe, Yasutaka;
    • Kato, Terufumi;
    • Hayakawa, Daisuke;
    • Tanaka, Hiroshi;
    • Takahashi, Toshiaki;
    • Kogure, Yoshihito;
    • Tachihara, Motoko;
    • Fujimoto, Daichi;
    • Yamaguchi, Kakuhiro;
    • Hamaguchi, Naohiko;
    • Okamoto, Isamu;
    • Azuma, Koichi;
    • Hasegawa, Kazuo;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    The malignant potential of pancreatic intraductal papillary mucinous neoplasm is reflected in expression levels of fucosylated glycans in α<sub>1</sub>‐acid glycoprotein.

    Published in:
    Journal of Hepato -- Biliary -- Pancreatic Sciences, 2023, v. 30, n. 4, p. 503, doi. 10.1002/jhbp.1208
    By:
    • Kubo, Norio;
    • Yazawa, Shin;
    • Yokobori, Takehiko;
    • Sano, Rie;
    • Eguchi, Hidetoshi;
    • Kobayashi, Shogo;
    • Akita, Hirofumi;
    • Mitsufuji, Suguru;
    • Yamashita, Yo‐ichi;
    • Nakao, Yosuke;
    • Fujii, Tsutomu;
    • Okumura, Tomoyuki;
    • Shibuya, Kazuto;
    • Hoshino, Yui;
    • Yamada, Suguru;
    • Hayashi, Masamichi;
    • Shimokawa, Mototsugu;
    • Shirabe, Ken
    Publication type:
    Article
    20

    Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

    Published in:
    World Journal of Surgery, 2019, v. 43, n. 11, p. 2894, doi. 10.1007/s00268-019-05085-w
    By:
    • Yamashita, Yo-ichi;
    • Hayashi, Hiromitsu;
    • Imai, Katsunori;
    • Okabe, Hirohisa;
    • Nakagawa, Shigeki;
    • Kitamura, Fumimasa;
    • Uemura, Norio;
    • Nakao, Yosuke;
    • Yusa, Toshihiko;
    • Itoyama, Rumi;
    • Yamao, Takanobu;
    • Umesaki, Naoki;
    • Miyata, Tatsunori;
    • Chikamoto, Akira;
    • Shimokawa, Mototsugu;
    • Baba, Hideo
    Publication type:
    Article
    21

    A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 3, p. 369, doi. 10.1007/s11523-023-00963-9
    By:
    • Izawa, Naoki;
    • Masuishi, Toshiki;
    • Takahashi, Naoki;
    • Shoji, Hirokazu;
    • Yamamoto, Yoshiyuki;
    • Matsumoto, Toshihiko;
    • Sugiyama, Keiji;
    • Kajiwara, Takeshi;
    • Kawakami, Kentaro;
    • Aomatsu, Naoki;
    • Kondoh, Chihiro;
    • Kawakami, Hisato;
    • Takegawa, Naoki;
    • Esaki, Taito;
    • Shimokawa, Mototsugu;
    • Nishio, Kazuto;
    • Narita, Yukiya;
    • Hara, Hiroki;
    • Sunakawa, Yu;
    • Boku, Narikazu
    Publication type:
    Article
    22
    23
    24
    25

    Expression of PD-L1, PD-L2, and IDO1 on tumor cells and density of CD8-positive tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma according to histological subtype.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 10, p. 2639, doi. 10.1007/s00432-020-03250-6
    By:
    • Takada, Kazuki;
    • Toyokawa, Gouji;
    • Kinoshita, Fumihiko;
    • Jogo, Tomoko;
    • Kohashi, Kenichi;
    • Wakasu, Sho;
    • Ono, Yuki;
    • Tanaka, Kensuke;
    • Oba, Taro;
    • Osoegawa, Atsushi;
    • Tagawa, Tetsuzo;
    • Azuma, Koichi;
    • Okamoto, Isamu;
    • Shimokawa, Mototsugu;
    • Oda, Yoshinao;
    • Mori, Masaki
    Publication type:
    Article
    26
    27
    28
    29
    30
    31

    Inflammatory prognostic factors in advanced or recurrent esophageal squamous cell carcinoma treated with nivolumab.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 427, doi. 10.1007/s00262-022-03265-7
    By:
    • Ikoma, Tatsuki;
    • Shimokawa, Mototsugu;
    • Matsumoto, Toshihiko;
    • Boku, Shogen;
    • Yasuda, Tomoyo;
    • Shibata, Nobuhiro;
    • Kurioka, Yusuke;
    • Takatani, Masahiro;
    • Nobuhisa, Tetsuji;
    • Namikawa, Tsutomu;
    • Kitagawa, Hiroyuki;
    • Hanazaki, Kazuhiro;
    • Doi, Keitaro;
    • Shimada, Takanobu;
    • Tsumura, Takehiko;
    • Marusawa, Hiroyuki;
    • Kanaya, Seichiro;
    • Morita, Shuko;
    • Inokuma, Tetsurou;
    • Nagai, Hiroki
    Publication type:
    Article
    32

    Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1745, doi. 10.1007/s00262-020-02783-6
    By:
    • Takamori, Shinkichi;
    • Takada, Kazuki;
    • Shimokawa, Mototsugu;
    • Jinnnouchi, Mikako;
    • Matsubara, Taichi;
    • Haratake, Naoki;
    • Miura, Naoko;
    • Toyozawa, Ryo;
    • Yamaguchi, Masafumi;
    • Takenoyama, Mitsuhiro;
    • Yoneshima, Yasuto;
    • Tanaka, Kentaro;
    • Okamoto, Isamu;
    • Tagawa, Tetsuzo;
    • Mori, Masaki
    Publication type:
    Article
    33

    Interleukin-38 promotes tumor growth through regulation of CD8+ tumor-infiltrating lymphocytes in lung cancer tumor microenvironment.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 1, p. 123, doi. 10.1007/s00262-020-02659-9
    By:
    • Kinoshita, Fumihiko;
    • Tagawa, Tetsuzo;
    • Akamine, Takaki;
    • Takada, Kazuki;
    • Yamada, Yuichi;
    • Oku, Yuka;
    • Kosai, Keisuke;
    • Ono, Yuki;
    • Tanaka, Kensuke;
    • Wakasu, Sho;
    • Oba, Taro;
    • Osoegawa, Atsushi;
    • Shimokawa, Mototsugu;
    • Oda, Yoshinao;
    • Hoshino, Tomoaki;
    • Mori, Masaki
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Multicenter Retrospective Analysis of Original versus Modified FOLFIRINOX in Metastatic Pancreatic Cancer: Results of the NAPOLEON Study.

    Published in:
    Oncology, 2023, v. 101, n. 1, p. 22, doi. 10.1159/000527176
    By:
    • Nakazawa, Junichi;
    • Tsuruta, Nobuhiro;
    • Shimokawa, Mototsugu;
    • Kawahira, Machiko;
    • Arima, Shiho;
    • Ido, Akio;
    • Koga, Futa;
    • Ueda, Yujiro;
    • Komori, Azusa;
    • Otsu, Satoshi;
    • Fukahori, Masaru;
    • Makiyama, Akitaka;
    • Taguchi, Hiroki;
    • Honda, Takuya;
    • Shibuki, Taro;
    • Nio, Kenta;
    • Ide, Yasushi;
    • Ureshino, Norio;
    • Mizuta, Toshihiko;
    • Otsuka, Taiga
    Publication type:
    Article
    46
    47
    48

    Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).

    Published in:
    Oncology, 2018, v. 94, n. 5, p. 289, doi. 10.1159/000486624
    By:
    • Tanioka, Hiroaki;
    • Miyamoto, Yuji;
    • Tsuji, Akihito;
    • Asayama, Masako;
    • Shiraishi, Takeshi;
    • Yuki, Satoshi;
    • Kotaka, Masahito;
    • Makiyama, Akitaka;
    • Shimokawa, Mototsugu;
    • Shimose, Takayuki;
    • Masuda, Satohiro;
    • Yamaguchi, Takuhiro;
    • Komatsu, Yoshito;
    • Saeki, Hiroshi;
    • Emi, Yasunori;
    • Baba, Hideo;
    • Oki, Eiji;
    • Maehara, Yoshihiko
    Publication type:
    Article
    49
    50